Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

Description

This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.

Conditions

Type 2 Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.

COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City

Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

Condition
Type 2 Diabetes
Intervention / Treatment

-

Contacts and Locations

Kansas City

University of Missouri - Kansas City School of Medicine, Kansas City, Missouri, United States, 64108

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Diagnosed with type 2 diabetes
  • 2. Age 18 to 65
  • 3. Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months
  • 4. Most recent hemoglobin A1c result between 8.0 and 11.0
  • 5. Currently receiving treatment for diabetes by a licensed healthcare provider.
  • 6. Reliable access to a personal smart phone that is compatible with CGM
  • 7. English speaking
  • 1. Type 1 diabetes
  • 2. Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease)
  • 3. Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan
  • 4. Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study
  • 5. Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Missouri, Kansas City,

Jared Bruce, PhD, PRINCIPAL_INVESTIGATOR, University of Missouri, Kansas City

Study Record Dates

2025-12-31